1317 – Bone Mineral Density using Dual Energy X-Ray Absorptiometry (DXA) in patients with HIV

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status -
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

New MBS item.

Service or technology in this application

This proposal is for the provision of an MBS item number for bone densitometry by DXA scan to women and men with HIV infection, regardless of whether or not they are using anti-retroviral therapy.

DXA scanning is considered the gold standard for the purposes of identifying patients with low BMD, predominately due to cost-effectiveness and accessibility. It documents small changes in bone mass and can also be used to examine both the spine and the extremities.

Type: Investigative

Medical condition this application addresses

Osteoporosis is a condition in which the bones become fragile and brittle, leading to a higher risk of fractures (breaks or cracks) than in normal bone.

Fractures due to osteoporosis (osteoporotic fractures) can lead to changes in, muscle weakness, loss of height and bone deformity of the spine. Fractures can lead to chronic pain, disability, loss of independence and even premature death.

Application documents

PICO confirmation

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Meetings to consider this application

  • PASC meeting: 
    • 16 - 17 August 2012
    • 13 - 14 December 2012
  • ESC meeting: -
  • MSAC meeting: -